XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 13.02.2024

XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 13.02.2024 - 5

The following instruments on Boerse Frankfurt do have their last trading day on 13.02.2024
Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 13.02.2024

ISIN Name
US87166L2097 SYNLOGIC INC. DL-,001
US87250W3016 BAIYU HOLD.I. NEW DL-,001
US88362L2097 THERMOGENESIS H.INC. NEW
US8902608541 TONIX PHA.NEW2023 DL-,001
US89846A4058 TRXADE HEALTH DL-,0001
US9221073052 VAPOTHERM INC. COM NEW
US92332W2044 VENUS CONCEPT INC. -,0001
US92337U2033 VERB TE.CO.INC DL-,0001
US92823T2078 VIRNETX HLG CP.NEW DL-001
US92836Y4098 VISLI.T.INC NEW DL-,00001
US9840156023 XENETIC BIOSCIE DL-,001
US98420U8027 XWELL INC.
US98880R2085 ZW DATA ACT.T.NEW DL-,001
VGG569812057 LUOKUNG TECH.CORP. DL-,30
VGG885761061 THUNDERBIRD RESORTS INC.

Nach Nvidia: 5 KI-Revolutionäre aus der zweiten Reihe!

Künstliche Intelligenz hat spätestens nach dem Raketenstart von Chat GPT das Leben aller verändert. Doch der Superzyklus steht nach Meinungen von Experten erst am Anfang. Während Aktien wie Nvidia von der ersten Aufwärtsentwicklung stark profitieren konnten, versprechen aussichtsreiche Player aus der

zweiten Reihe noch enormes Aufwärtspotenzial.

Im kostenlosen, exklusiven Spezialreport präsentieren wir ihnen 5 innovative KI-Unternehmen, die bahnbrechende Entwicklungen in diesem Sektor prägen könnten.

Warum sollten Sie dabei sein?
Trotz der jüngsten Erfolge steht die Entwicklung der künstlichen Intelligenz noch am Beginn eines neuen Superzyklus. Experten gehen davon aus, dass der Sektor bis 2032 global auf 1,3 Billionen US-Dollar explodieren wird, wobei ein großer Teil auf Hardware und Infrastruktur entfallen wird.

Nutzen Sie die Chance!
Fordern Sie sofort unseren brandneuen Spezialreport an und erfahren Sie, welche 5 KI-Aktien das größte Potenzial zur Vervielfachung besitzen. Dieser Report ist komplett kostenlos und zeigt Ihnen die aussichtsreichsten Investments im KI-Sektor.
Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Hier klicken

Zeit	Aktuelle Nachrichten
26.08.	Agility Real Estate Inc.: Agility asset sale, escrow settlement, debt paydown, 50:1 reverse split and officer share purchase	TAMPA, FL, UNITED STATES OF AMERICA, August 26, 2024 -- Agility Real Estate Inc. ("Agility") (Euronext: AGIL) is pleased to announce the following material events: 1. ASSET SALE & ESCROW SETTLEMENT:... ► Artikel lesen
13.02.	XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 13.02.2024 - 5	The following instruments on Boerse Frankfurt do have their last trading day on 13.02.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 13.02.2024ISIN NameUS87166L2097 SYNLOGIC... ► Artikel lesen
31.01.	Thunderbird Resorts Inc.: January 2024 AGM Results - Change of Corporate Name to Agility Real Estate Inc.	Thunderbird Resorts Inc. ("Thunderbird" or "Group") (NYSE Euronext Amsterdam: TBIRD) reports the following results of the Company's Annual General Meeting of Shareholders held in La Mesa, California... ► Artikel lesen

Zeit

Aktuelle Nachrichten

26.08.

Agility Real Estate Inc.: Agility asset sale, escrow settlement, debt paydown, 50:1 reverse split and officer share purchase

TAMPA, FL, UNITED STATES OF AMERICA, August 26, 2024 -- Agility Real Estate Inc. ("Agility") (Euronext: AGIL) is pleased to announce the following material events: 1. ASSET SALE & ESCROW SETTLEMENT:...
► Artikel lesen

13.02.

XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 13.02.2024 - 5

31.01.

Thunderbird Resorts Inc.: January 2024 AGM Results - Change of Corporate Name to Agility Real Estate Inc.

Thunderbird Resorts Inc. ("Thunderbird" or "Group") (NYSE Euronext Amsterdam: TBIRD) reports the following results of the Company's Annual General Meeting of Shareholders held in La Mesa, California...
► Artikel lesen

Zeit	Aktuelle Nachrichten
Fr	BAIYU Holdings, Inc. - 8-K, Current Report
13.11.	BAIYU Holdings, Inc. - 10-Q, Quarterly Report
30.10.	BAIYU Holdings unterzeichnet Vertrag zur Stärkung der Lithiumbatterie-Lieferkette
30.10.	BAIYU Holdings inks deal to solidify lithium battery supply
18.10.	China's Baiyu Pharma Grants Exclusive Global Rights for Its Innovative Cancer Drug to Sweden's Novartis

Zeit

Aktuelle Nachrichten

BAIYU Holdings, Inc. - 8-K, Current Report

13.11.

BAIYU Holdings, Inc. - 10-Q, Quarterly Report

30.10.

BAIYU Holdings unterzeichnet Vertrag zur Stärkung der Lithiumbatterie-Lieferkette

30.10.

BAIYU Holdings inks deal to solidify lithium battery supply

18.10.

China's Baiyu Pharma Grants Exclusive Global Rights for Its Innovative Cancer Drug to Sweden's Novartis

Zeit	Aktuelle Nachrichten
05.11.	LKCO stock touches 52-week low at $1.73 amid market challenges
05.11.	LKCO-Aktie erreicht 52-Wochen-Tief bei 1,73 US-Dollar
25.10.	Luokung receives additional non-compliance notice from Nasdaq
25.10.	Luokung Technology Corp.: Luokung Announces Receipt of Nasdaq Notices Regarding Periodic Filing Compliance and Stockholders' Equity Deficiency	BEIJING, Oct. 25, 2024 (GLOBE NEWSWIRE) -- Luokung Technology Corp. (NASDAQ: LKCO) ("Luokung" or the "Company"), a leading spatial-temporal intelligent big data services company and provider of interactive... ► Artikel lesen
25.10.	Luokung Technology Corp. - 6-K, Report of foreign issuer

Zeit

Aktuelle Nachrichten

05.11.

LKCO stock touches 52-week low at $1.73 amid market challenges

05.11.

LKCO-Aktie erreicht 52-Wochen-Tief bei 1,73 US-Dollar

25.10.

Luokung receives additional non-compliance notice from Nasdaq

25.10.

Luokung Technology Corp.: Luokung Announces Receipt of Nasdaq Notices Regarding Periodic Filing Compliance and Stockholders' Equity Deficiency

BEIJING, Oct. 25, 2024 (GLOBE NEWSWIRE) -- Luokung Technology Corp. (NASDAQ: LKCO) ("Luokung" or the "Company"), a leading spatial-temporal intelligent big data services company and provider of interactive...
► Artikel lesen

25.10.

Luokung Technology Corp. - 6-K, Report of foreign issuer

Zeit	Aktuelle Nachrichten
06.11.	Scienture Holdings, Inc. - 10-Q, Quarterly Report
11.10.	Scienture schließt Umwandlung von Vorzugsaktien ab
11.10.	Scienture completes preferred stock conversion
08.10.	Scienture Holdings, Inc. - 8-K, Current Report
24.09.	Scienture Holdings, Inc. - 8-K, Current Report

Zeit

Aktuelle Nachrichten

06.11.

Scienture Holdings, Inc. - 10-Q, Quarterly Report

11.10.

Scienture schließt Umwandlung von Vorzugsaktien ab

11.10.

Scienture completes preferred stock conversion

08.10.

Scienture Holdings, Inc. - 8-K, Current Report

24.09.

Scienture Holdings, Inc. - 8-K, Current Report

Zeit	Aktuelle Nachrichten
15.11.	Synlogic Inc reports results for the quarter ended September 30 - Earnings Summary
12.11.	Synlogic GAAP EPS of -$0.01
12.11.	Synlogic, Inc.: Synlogic Reports Third Quarter 2024 Financial Results	WINCHESTER, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a biopharmaceutical company advancing novel therapeutics to transform the care of serious diseases, today reported... ► Artikel lesen
12.11.	SYNLOGIC, INC. - S-8, Securities to be offered to employees in employee benefit plans
12.11.	SYNLOGIC, INC. - 10-Q, Quarterly Report

Zeit

Aktuelle Nachrichten

15.11.

Synlogic Inc reports results for the quarter ended September 30 - Earnings Summary

12.11.

Synlogic GAAP EPS of -$0.01

12.11.

Synlogic, Inc.: Synlogic Reports Third Quarter 2024 Financial Results

WINCHESTER, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a biopharmaceutical company advancing novel therapeutics to transform the care of serious diseases, today reported...
► Artikel lesen

12.11.

SYNLOGIC, INC. - S-8, Securities to be offered to employees in employee benefit plans

12.11.

SYNLOGIC, INC. - 10-Q, Quarterly Report

Zeit	Aktuelle Nachrichten
15.08.	ThermoGenesis Holdings, Inc. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB
06.08.	ThermoGenesis Holdings, Inc. - 8-K, Current Report
16.07.	ThermoGenesis Holdings, Inc. - 8-K, Current Report
28.06.	NSE - ThermoGenesis Holdings, Inc. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities
26.06.	ThermoGenesis Holdings, Inc. - 8-K, Current Report

Zeit

Aktuelle Nachrichten

15.08.

ThermoGenesis Holdings, Inc. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB

06.08.

ThermoGenesis Holdings, Inc. - 8-K, Current Report

16.07.

ThermoGenesis Holdings, Inc. - 8-K, Current Report

28.06.

NSE - ThermoGenesis Holdings, Inc. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities

26.06.

ThermoGenesis Holdings, Inc. - 8-K, Current Report

Zeit	Aktuelle Nachrichten
Fr	Looking Into Tonix Pharmaceuticals' Recent Short Interest
Mo	Tonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals to Present at the Winter 2024 Investor Summit Virtual
Mo	Tonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting
14.11.	Tonix Pharmaceuticals Holding: Tonix Pharmaceuticals Targets Rapid Migraine Relief With Non-Oral Treatments	This post was written and published as a collaboration between the in-house editorial team at Benzinga and Tonix Pharmaceuticals Holding Corp. with financial support from Tonix. The two organizations... ► Artikel lesen
13.11.	Tonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Announces Poster Presentation at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting

Zeit

Aktuelle Nachrichten

Looking Into Tonix Pharmaceuticals' Recent Short Interest

Tonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals to Present at the Winter 2024 Investor Summit Virtual

Tonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting

14.11.

Tonix Pharmaceuticals Holding: Tonix Pharmaceuticals Targets Rapid Migraine Relief With Non-Oral Treatments

This post was written and published as a collaboration between the in-house editorial team at Benzinga and Tonix Pharmaceuticals Holding Corp. with financial support from Tonix. The two organizations...
► Artikel lesen

13.11.

Tonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Announces Poster Presentation at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting

Zeit	Aktuelle Nachrichten
25.09.	VAPOTHERM INC - 15-12G, Securities registration termination
24.09.	Vapotherm director James Liken sells $15,956 in stock, disposes of additional $119,481 worth
20.09.	Vapotherm, Inc.: Vapotherm Announces Closing of Merger	EXETER, N.H., Sept. 20, 2024 /PRNewswire/ -- Vapotherm, Inc. (OTCQX: VAPO), ("Vapotherm" or the "Company"), announced today that it has closed its merger with a newly-formed entity organized and... ► Artikel lesen
19.09.	VAPOTHERM INC - 8-K, Current Report
13.08.	Vapotherm GAAP EPS of -$2.22, revenue of $16.9M

Zeit

Aktuelle Nachrichten

25.09.

VAPOTHERM INC - 15-12G, Securities registration termination

24.09.

Vapotherm director James Liken sells $15,956 in stock, disposes of additional $119,481 worth

20.09.

Vapotherm, Inc.: Vapotherm Announces Closing of Merger

EXETER, N.H., Sept. 20, 2024 /PRNewswire/ -- Vapotherm, Inc. (OTCQX: VAPO), ("Vapotherm" or the "Company"), announced today that it has closed its merger with a newly-formed entity organized and...
► Artikel lesen

19.09.

VAPOTHERM INC - 8-K, Current Report

13.08.

Vapotherm GAAP EPS of -$2.22, revenue of $16.9M

Zeit	Aktuelle Nachrichten
13.11.	Venus Concept misses top-line and bottom-line estimates; initiates Q424 outlook
13.11.	Venus Concept Inc.: Venus Concept Announces Third Quarter of Fiscal Year 2024 Financial Results	TORONTO, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three... ► Artikel lesen
13.11.	Venus Concept Inc. - 10-Q, Quarterly Report
13.11.	Venus Concept Inc. - 8-K, Current Report
07.11.	Venus Concept expands global distributor network

Zeit

Aktuelle Nachrichten

13.11.

Venus Concept misses top-line and bottom-line estimates; initiates Q424 outlook

13.11.

Venus Concept Inc.: Venus Concept Announces Third Quarter of Fiscal Year 2024 Financial Results

TORONTO, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three...
► Artikel lesen

13.11.

Venus Concept Inc. - 10-Q, Quarterly Report

13.11.

Venus Concept Inc. - 8-K, Current Report

07.11.

Venus Concept expands global distributor network

Zeit	Aktuelle Nachrichten
Fr	Verb Technology Company, Inc.: VERB CEO to Participate in Nasdaq's 'Ring in the Races' Closing Bell Ceremony Live at F1 in Las Vegas
12.11.	Verb Technology reports Q3 results
05.11.	Verb Technology Company, Inc. - 10-Q, Quarterly Report
28.10.	Verb Technology erfüllt wieder Nasdaq-Anforderungen für Aktienkurs
28.10.	Verb Technology Company, Inc. - 8-K, Current Report

Zeit

Aktuelle Nachrichten

Verb Technology Company, Inc.: VERB CEO to Participate in Nasdaq's 'Ring in the Races' Closing Bell Ceremony Live at F1 in Las Vegas

12.11.

Verb Technology reports Q3 results

05.11.

Verb Technology Company, Inc. - 10-Q, Quarterly Report

28.10.

Verb Technology erfüllt wieder Nasdaq-Anforderungen für Aktienkurs

28.10.

Verb Technology Company, Inc. - 8-K, Current Report

Zeit	Aktuelle Nachrichten
13.11.	VirnetX Holding Corp - 10-Q, Quarterly Report
04.09.	VirnetX Holding Corp - 8-K, Current Report
14.08.	VirnetX Holding Corp - S-8, Securities to be offered to employees in employee benefit plans
18.06.	VirnetX Holding Corp - 8-K, Current Report
13.02.	XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 13.02.2024 - 5	The following instruments on Boerse Frankfurt do have their last trading day on 13.02.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 13.02.2024ISIN NameUS87166L2097 SYNLOGIC... ► Artikel lesen

Zeit

Aktuelle Nachrichten

13.11.

VirnetX Holding Corp - 10-Q, Quarterly Report

04.09.

VirnetX Holding Corp - 8-K, Current Report

14.08.

VirnetX Holding Corp - S-8, Securities to be offered to employees in employee benefit plans

18.06.

VirnetX Holding Corp - 8-K, Current Report

13.02.

XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 13.02.2024 - 5

Zeit	Aktuelle Nachrichten
14.11.	Vislink Technologies Inc reports results for the quarter ended September 30 - Earnings Summary
14.11.	Vislink Technologies, Inc. - 10-Q, Quarterly Report
14.11.	Vislink Technologies GAAP EPS of -$1.22 misses by $0.49, revenue of $7.07M misses by $1.4M
14.11.	Vislink Technologies, Inc.: Vislink Reports Third Quarter 2024 Financial and Operational Results	Year-to-Date Revenue Increased 26% Year-Over-Year to $24.4 Million New ERP Implementation Insights lead to Restructuring Initiative Expected to Achieve Over $6 Million in Annualized Cost Savings... ► Artikel lesen
14.11.	Vislink Technologies, Inc. - 8-K, Current Report

Zeit

Aktuelle Nachrichten

14.11.

Vislink Technologies Inc reports results for the quarter ended September 30 - Earnings Summary

14.11.

Vislink Technologies, Inc. - 10-Q, Quarterly Report

14.11.

Vislink Technologies GAAP EPS of -$1.22 misses by $0.49, revenue of $7.07M misses by $1.4M

14.11.

Vislink Technologies, Inc.: Vislink Reports Third Quarter 2024 Financial and Operational Results

Year-to-Date Revenue Increased 26% Year-Over-Year to $24.4 Million New ERP Implementation Insights lead to Restructuring Initiative Expected to Achieve Over $6 Million in Annualized Cost Savings...
► Artikel lesen

14.11.

Vislink Technologies, Inc. - 8-K, Current Report

Zeit	Aktuelle Nachrichten
Fr	Xenetic Biosciences, Inc. Releases Virtual Investor "What This Means" Segment	Dr. Reid Bissonnette, Executive Consultant for Translational Research and Development at Xenetic, discusses positive preclinical data recently presented at the Society for Immunotherapy of Cancer (SITC)... ► Artikel lesen
Do	Xenetic Biosciences, Inc. Presents Positive Preclinical Data Highlighting the Potential of Co-Administration of DNase I with CAR T Cells in a Murine Model of Melanoma Lung Metastasis	Data presented at the AACR Special Conference in Cancer Research: Tumor-body Interactions: The Roles of Micro- and Macroenvironment in CancerResults bolster Company's rationale for incorporating DNase... ► Artikel lesen
13.11.	Xenetic Biosciences GAAP EPS of -$0.28, revenue of $614.1M
13.11.	Xenetic Biosciences Inc reports results for the quarter ended September 30 - Earnings Summary
13.11.	Xenetic Biosciences, Inc. Reports Third Quarter 2024 Financial Results	Establishing growing body of preclinical data evaluating the DNase-based oncology platform across a number of high-value oncology indicationsOngoing progress towards first in human clinical study for... ► Artikel lesen

Zeit

Aktuelle Nachrichten

Xenetic Biosciences, Inc. Releases Virtual Investor "What This Means" Segment

Dr. Reid Bissonnette, Executive Consultant for Translational Research and Development at Xenetic, discusses positive preclinical data recently presented at the Society for Immunotherapy of Cancer (SITC)...
► Artikel lesen

Xenetic Biosciences, Inc. Presents Positive Preclinical Data Highlighting the Potential of Co-Administration of DNase I with CAR T Cells in a Murine Model of Melanoma Lung Metastasis

Data presented at the AACR Special Conference in Cancer Research: Tumor-body Interactions: The Roles of Micro- and Macroenvironment in CancerResults bolster Company's rationale for incorporating DNase...
► Artikel lesen

13.11.

Xenetic Biosciences GAAP EPS of -$0.28, revenue of $614.1M

13.11.

Xenetic Biosciences Inc reports results for the quarter ended September 30 - Earnings Summary

13.11.

Xenetic Biosciences, Inc. Reports Third Quarter 2024 Financial Results

Establishing growing body of preclinical data evaluating the DNase-based oncology platform across a number of high-value oncology indicationsOngoing progress towards first in human clinical study for...
► Artikel lesen

Zeit	Aktuelle Nachrichten
14.11.	XWELL reports Q3 results
14.11.	XWELL, Inc. Reports Third Quarter 2024 Results	NEW YORK, Nov. 14, 2024 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), an authority in wellness solutions for people on the go, today reported results for the third quarter... ► Artikel lesen
14.11.	XWELL, Inc. - 8-K, Current Report
14.11.	XWELL, Inc. - 10-Q, Quarterly Report
12.11.	XWELL, Inc. to Report Third Quarter 2024 Results on Thursday, November 14, 2024

Zeit

Aktuelle Nachrichten

14.11.

XWELL reports Q3 results

14.11.

XWELL, Inc. Reports Third Quarter 2024 Results

NEW YORK, Nov. 14, 2024 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), an authority in wellness solutions for people on the go, today reported results for the third quarter...
► Artikel lesen

14.11.

XWELL, Inc. - 8-K, Current Report

14.11.

XWELL, Inc. - 10-Q, Quarterly Report

12.11.

XWELL, Inc. to Report Third Quarter 2024 Results on Thursday, November 14, 2024

Zeit	Aktuelle Nachrichten
Di	ZW Data Action Technologies Inc. - 10-Q, Quarterly Report
04.10.	ZW Data Action Technologies Inc. - 8-K, Current Report
27.09.	ZW Data Action Technologies schließt Vereinbarung mit Direktor
25.09.	ZW Data enacts reverse stock split to meet Nasdaq requirements
25.09.	ZW Data führt Aktienzusammenlegung durch, um Nasdaq-Anforderungen zu erfüllen

Zeit

Aktuelle Nachrichten

ZW Data Action Technologies Inc. - 10-Q, Quarterly Report

04.10.

ZW Data Action Technologies Inc. - 8-K, Current Report

27.09.

ZW Data Action Technologies schließt Vereinbarung mit Direktor

25.09.

ZW Data enacts reverse stock split to meet Nasdaq requirements

25.09.

ZW Data führt Aktienzusammenlegung durch, um Nasdaq-Anforderungen zu erfüllen

Unternehmen / Aktien	Kurs	%
AGILITY REAL ESTATE INC	0,064	0,00 %
BAIYU HOLDINGS INC	0,179	0,00 %
LUOKUNG TECHNOLOGY CORP ADR	1,660	0,00 %
SCIENTURE HOLDINGS INC	7,738	-2,59 %
SYNLOGIC INC	1,470	+5,00 %
THERMOGENESIS HOLDINGS INC	0,290	0,00 %
TONIX PHARMACEUTICALS HOLDING CORP	0,190	-7,00 %
VAPOTHERM INC	1,130	0,00 %
VENUS CONCEPT INC	0,313	+7,97 %
VERB TECHNOLOGY COMPANY INC	8,960	+8,34 %
VIRNETX HOLDING CORPORATION	5,150	+1,58 %
VISLINK TECHNOLOGIES INC	4,250	-3,63 %
XENETIC BIOSCIENCES INC	4,070	+3,83 %
XWELL INC	1,460	+5,04 %
ZW DATA ACTION TECHNOLOGIES INC	1,650	+3,77 %

Unternehmen / Aktien

Kurs

AGILITY REAL ESTATE INC

0,064

0,00 %

BAIYU HOLDINGS INC

0,179

0,00 %

LUOKUNG TECHNOLOGY CORP ADR

1,660

0,00 %

SCIENTURE HOLDINGS INC